论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
LDH 和 CRP 在宫颈癌中的预后价值
Authors Wang H, Wang MS, Zhou YH, Shi JP, Wang WJ
Received 17 October 2019
Accepted for publication 20 January 2020
Published 11 February 2020 Volume 2020:13 Pages 1255—1263
DOI https://doi.org/10.2147/OTT.S235027
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 3
Editor who approved publication: Dr Sanjay Singh
Purpose: Cervical cancer is one of the deadliest tumors among women in China. C-reactive protein (CRP), an indicator of inflammation, and lactate dehydrogenase (LDH), an enzyme ubiquitously expressed in cells, both play important roles in tumor growth and metastasis.
Patients and Methods: Based on pre-radiotherapy LDH and CRP median levels, we divided patients into four groups: high LDH and CRP group, high LDH group, high CRP group, and low LDH and CRP group. Then, based on pre-/post-radiotherapy LDH and CRP ratios, we divided patients into four groups: high LDH and CRP ratio group, high LDH ratio group, high CRP ratio group, and low LDH and CRP ratio group. Kaplan–Meier (KM) curves were constructed to show overall survival (OS). A multivariate Cox regression model was employed to identify the independent risk factors.
Results: High pre-radiotherapy LDH and CRP levels and increased pre-/post-radiotherapy LDH and CRP ratios were correlated with worst OS compared with the other three groups.
Conclusion: LDH and CRP were correlated with outcomes in patients with locally advanced cervical cancer.
Keywords: cervical cancer, LDH, CRP, prognosis, OS
